| Business Summary | | Coronado
Industries,
Inc.,
a
holding
company,
manufactures
and
markets
a
fixation
device
for
the
treatment
of
open
angle
and
pigmentary
glaucoma,
through
its
subsidiary,
Ophthalmic
International,
L.L.C.
A
two-minute
treatment
with
the
Company's
vacuum
fixation
device
and
patented
design
suction
ring
temporarily
reduce
inter-ocular
pressure
(IOP)
in
the
treatment
of
open
angle
glaucoma
by
approximately
6
Hg
for
an
average
of
three
months,
at
which
time
the
treatment
can
be
repeated
with
no
serious
side
effects.
This
IOP
lowering
is
achieved
when
the
external
suction
device
is
applied
over
the
perilimbal
area
for
a
specified
time.
This
treatment
is
designed
to
have
no
harmful
side
effects,
like
those
associated
with
eye
drop
treatments.
In
addition,
the
patent,
Open
Angle
Glaucoma
Treatment
Apparatus
and
Method,
has
been
approved.
The
Company's
other
subsidiary,
American
Glaucoma,
operated
a
glaucoma
treatment
center
in
Scottsdale,
Arizona,
from
September
1997
to
March
1999. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Coronado
Industries,
Inc.,
through
Ophthalmic
International,
Inc.,
manufactures
and
markets
a
vacuum
fixation
device
with
a
patented
designed
suction
ring
that
treats
Open
Angle
and
Pigmentary
glaucoma.
For
the
six
months
ended
6/30/01,
the
Company
reported
no
revenues.
Net
loss
fell
35%
to
$773
thousand.
Results
reflect
a
decrease
in
public
relations
and
legal
expenses
as
well
as
decreased
rent
expenses. | More
from
Market Guide: Significant
Developments |
| | |
| Position | G. Smith, 51 | Chairman,
and Sec., | Gary Smith, 55 | Pres,
Treasurer, |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|